These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12005275)

  • 21. Rizatriptan for acute migraine.
    Oldman AD; Smith LA; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2001; (3):CD003221. PubMed ID: 11687054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
    Savi L; Mogavero S; Egan CG
    Drug Des Devel Ther; 2014; 8():983-92. PubMed ID: 25092964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
    Goldstein J; Ryan R; Jiang K; Getson A; Norman B; Block GA; Lines C
    Headache; 1998; 38(10):737-47. PubMed ID: 11284462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.
    Tfelt-Hansen P; Teall J; Rodriguez F; Giacovazzo M; Paz J; Malbecq W; Block GA; Reines SA; Visser WH
    Headache; 1998; 38(10):748-55. PubMed ID: 11284463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rizatriptan in the treatment of menstrual migraine.
    Silberstein SD; Massiou H; Le Jeunne C; Johnson-Pratt L; McCarroll KA; Lines CR
    Obstet Gynecol; 2000 Aug; 96(2):237-42. PubMed ID: 10908770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.
    Silberstein SD; Massiou H; McCarroll KA; Lines CR
    Headache; 2002 Oct; 42(9):917-23. PubMed ID: 12390621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
    Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F
    Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Within-patient consistency of response of rizatriptan for treating migraine.
    Dahlöf CG; Lipton RB; McCarroll KA; Kramer MS; Lines CR; Ferrari MD
    Neurology; 2000 Nov; 55(10):1511-6. PubMed ID: 11094106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early treatment of migraine with rizatriptan: a placebo-controlled study.
    Mathew NT; Kailasam J; Meadors L
    Headache; 2004; 44(7):669-73. PubMed ID: 15209688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WITHDRAWN: Rizatriptan for acute migraine.
    Oldman AD; Smith LA; McQuay HJ; Moore RA
    Cochrane Database Syst Rev; 2007 Jul; 2001(1):CD003221. PubMed ID: 17636717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study. Naratriptan S2WA3001 Study Group.
    Klassen A; Elkind A; Asgharnejad M; Webster C; Laurenza A
    Headache; 1997; 37(10):640-5. PubMed ID: 9439085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
    Ahrens SP; Farmer MV; Williams DL; Willoughby E; Jiang K; Block GA; Visser WH
    Cephalalgia; 1999 Jun; 19(5):525-30. PubMed ID: 10403069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups.
    Block GA; Goldstein J; Polis A; Reines SA; Smith ME
    Headache; 1998; 38(10):764-71. PubMed ID: 11284464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized trial of rizatriptan in migraine attacks in children.
    Ahonen K; Hämäläinen ML; Eerola M; Hoppu K
    Neurology; 2006 Oct; 67(7):1135-40. PubMed ID: 16943370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials.
    Ferrari MD; Loder E; McCarroll KA; Lines CR
    Cephalalgia; 2001 Mar; 21(2):129-36. PubMed ID: 11422095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rizatriptan: pharmacological differences from sumatriptan and clinical results.
    Lines CR; McCarroll KA; Visser WH
    Curr Med Res Opin; 2001; 17 Suppl 1():s54-8. PubMed ID: 12463279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
    Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
    Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.